Defining the chromatin landscape in demyelinating disorders

Neurobiology of Disease

Volumn 39, Issue 1, 2010, Pages 47-52

  Huynh, Jimmy Long ^a   Casaccia, Patrizia ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Demyelination; Epigenetics; Multiple sclerosis; Myelin; Oligodendrocyte differentiation

Indexed keywords

HISTONE; MICRORNA; MYELIN BASIC PROTEIN;

ACETYLATION; CELL DIFFERENTIATION; CELL LINEAGE; CHROMATIN; CHROMATIN LANDSCAPE; CHROMATIN STRUCTURE; DEACETYLATION; DEMYELINATING DISEASE; DNA METHYLATION; DNA MODIFICATION; GENE EXPRESSION; GENE LOCATION; GENE SILENCING; HUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; REGULATORY MECHANISM; REMYELINIZATION; REVIEW;

ANIMALS; CELL DIFFERENTIATION; CHROMATIN; DEMYELINATING DISEASES; EPIGENESIS, GENETIC; HUMANS; MULTIPLE SCLEROSIS; STEM CELLS;

EID: 77952885093     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2009.10.014     Document Type: Review

References (95)

1. Bartova E., Krejci J., Harnicarova A., Galiova G., Kozubek S. Histone modifications and nuclear architecture: a review. J. Histochem. Cytochem. 2008, 56:711-721.
2. Bauer U.M., Daujat S., Nielsen S.J., Nightingale K., Kouzarides T. Methylation at arginine 17 of histone H3 is linked to gene activation. EMBO Rep. 2002, 3:39-44.
3. Bernstein E., Hake S.B. The nucleosome: a little variation goes a long way. Biochem. Cell Biol. 2006, 84:505-517.
4. Casaccia-Bonnefil P., Pandozy G., Mastronardi F. Evaluating epigenetic landmarks in the brain of multiple sclerosis patients: a contribution to the current debate on disease pathogenesis. Prog. Neurobiol. 2008, 86:368-378.
5. Cedar H., Bergman Y. Linking DNA methylation and histone modification: patterns and paradigms. Nat. Rev. Genet. 2009, 10:295-304.
6. Chan J.A., Krichevsky A.M., Kosik K.S. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 2005, 65:6029-6033.
7. Chen D., Ma H., Hong H., Koh S.S., Huang S.M., Schurter B.T., Aswad D.W., Stallcup M.R. Regulation of transcription by a protein methyltransferase. Science 1999, 284:2174-2177.
8. Cohen M., Lee K.K., Wilson K.L., Gruenbaum Y. Transcriptional repression, apoptosis, human disease and the functional evolution of the nuclear lamina. Trends Biochem. Sci. 2001, 26:41-47.
9. Copray S., Huynh J.L., Sher F., Casaccia-Bonnefil P., Boddeke E. Epigenetic mechanisms facilitating oligodendrocyte development, maturation, and aging. Glia 2009, 57:1579-1587.
10. Creyghton M.P., Markoulaki S., Levine S.S., Hanna J., Lodato M.A., Sha K., Young R.A., Jaenisch R., Boyer L.A. H2AZ is enriched at polycomb complex target genes in ES cells and is necessary for lineage commitment. Cell 2008, 135:649-661.
11. Davey C.A., Sargent D.F., Luger K., Maeder A.W., Richmond T.J. Solvent mediated interactions in the structure of the nucleosome core particle at 1.9 Å resolution. J. Mol. Biol. 2002, 319:1097-1113.
12. De Sandre-Giovannoli A., Chaouch M., Kozlov S., Vallat J.M., Tazir M., Kassouri N., Szepetowski P., Hammadouche T., Vandenberghe A., Stewart C.L., Grid D., Lévy N. Homozygous defects in LMNA, encoding lamin A/C nuclear-envelope proteins, cause autosomal recessive axonal neuropathy in human (Charcot-Marie-Tooth disorder type 2) and mouse. Am. J. Hum. Genet. 2002, 70:726-736.
13. Di Liegro I., Cestelli A. The relative proportion of H1(0) and A24 is reversed in oligodendrocytes during rat brain development. Cell. Mol. Neurobiol. 1990, 10:267-274.
14. Dickey J.S., Redon C.E., Nakamura A.J., Baird B.J., Sedelnikova O.A., Bonner W.M. H2AX: functional roles and potential applications. Chromosoma 2009, 10.1007/s00412-009-0234-4.
15. Eden S., Hashimshony T., Keshet I., Thorne A.W., Cedar H. DNA methylation models histone acetylation. Nature 1998, 394:842-843.
16. Fancy S.P., Baranzini S.E., Zhao C., Yuk D.I., Irvine K.A., Kaing S., Sanai N., Franklin R.J., Rowitch D.H. Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS. Genes Dev. 2009, 23:1571-1585.
17. Flynn S.W., Lang D.J., Mackay A.L., Goghari V., Vavasour I.M., Whittall K.P., Smith G.N., Arango V., Mann J.J., Dwork A.J., Falkai P., Honer W.G. Abnormalities of myelination in schizophrenia detected in vivo with MRI, and post-mortem with analysis of oligodendrocyte proteins. Mol. Psychiatry 2003, 8:811-820.
18. Grubinska B., Laszkiewicz I., Royland J., Wiggins R.C., Konat G.W. Differentiation-specific demethylation of myelin associated glycoprotein gene in cultured oligodendrocytes. J. Neurosci. Res. 1994, 39:233-242.
19. Haroutunian V., Katsel P., Dracheva S., Stewart D.G., Davis K.L. Variations in oligodendrocyte-related gene expression across multiple cortical regions: implications for the pathophysiology of schizophrenia. Int. J. Neuropsychopharmacol. 2007, 10:565-573.
20. Hashimshony T., Zhang J., Keshet I., Bustin M., Cedar H. The role of DNA methylation in setting up chromatin structure during development. Nat. Genet. 2003, 34:187-192.
21. He Y., Dupree J., Wang J., Sandoval J., Li J., Liu H., Shi Y., Nave K.A., Casaccia-Bonnefil P. The transcription factor Yin Yang 1 is essential for oligodendrocyte progenitor differentiation. Neuron 2007, 55:217-230.
22. He Y., Sandoval J., Casaccia-Bonnefil P. Events at the transition between cell cycle exit and oligodendrocyte progenitor differentiation: the role of HDAC and YY1. Neuron Glia Biol. 2007, 3:221-231.
23. Hébert S.S., Horré K., Nicolaï L., Papadopoulou A.S., Mandemakers W., Silahtaroglu A.N., Kauppinen S., Delacourte A., De Strooper B. Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:6415-6420.
24. Honer W.G., Falkai P., Chen C., Arango V., Mann J.J., Dwork A.J. Synaptic and plasticity-associated proteins in anterior frontal cortex in severe mental illness. Neuroscience 1999, 91:1247-1255.
25. Hua S., Kallen C.B., Dhar R., Baquero M.T., Mason C.E., Russell B.A., Shah P.K., Liu J., Khramtsov A., Tretiakova M.S., Krausz T.N., Olopade O.I., Rimm D.L., White K.P. Genomic analysis of estrogen cascade reveals histone variant H2A.Z associated with breast cancer progression. Mol. Syst. Biol. 2008, 4:188.
26. Iwamoto K., Bundo M., Yamada K., Takao H., Iwayama-Shigeno Y., Yoshikawa T., Kato T. DNA methylation status of SOX10 correlates with its downregulation and oligodendrocyte dysfunction in schizophrenia. J. Neurosci. 2005, 25:5376-5381.
27. Izzo A., Kamieniarz K., Schneider R. The histone H1 family: specific members, specific functions?. Biol. Chem. 2008, 389:333-343.
28. Kamakaka R.T., Biggins S. Histone variants: deviants?. Genes Dev. 2005, 19:295-310.
29. Kim D.H., Saetrom P., Snøve O., Rossi J.J. MicroRNA-directed transcriptional gene silencing in mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:16230-16235.
30. Kim V.N., Han J., Siomi M.C. Biogenesis of small RNAs in animals. Nat. Rev. Mol. Cell Biol. 2009, 10:126-139.
31. Kokandakar H.R., Tembhare P.R., Mamoon A., Mulay V.M., Bhople K.S. Acute basophilic leukaemia: a case report. Indian J. Pathol. Microbiol. 2007, 50:443-446.
32. Kondo T., Raff M. Basic helix-loop-helix proteins and the timing of oligodendrocyte differentiation. Development 2000, 127:2989-2998.
33. Kondo T., Raff M. The Id4 HLH protein and the timing of oligodendrocyte differentiation. EMBO J. 2000, 19:1998-2007.
34. Kornberg R.D., Thomas J.O. Chromatin structure; oligomers of the histones. Science 1974, 184:865-868.
35. Kozik M.B. The electron-microscopic picture of postnatal development of oligodendroglia. Folia Histochem. Cytochem. (Krakow). 1976, 14:99-106.
36. Lau P., Verrier J.D., Nielsen J.A., Johnson K.R., Notterpek L., Hudson L.D. Identification of dynamically regulated microRNA and mRNA networks in developing oligodendrocytes. J. Neurosci. 2008, 28:11720-11730.
37. Li B., Carey M., Workman J.L. The role of chromatin during transcription. Cell 2007, 128:707-719.
38. Li, H., He, Y., Richardson, W.D., Casaccia, P., 2009. Two-tier transcriptional control of oligodendrocyte differentiation. Curr. Opin. Neurobiol. 19, 479--485.
39. Lin S.T., Fu Y.H. miR-23 regulation of lamin B1 is crucial for oligodendrocyte development and myelination. Dis. Model Mech. 2009, 2:178-188.
40. Liu A., Li J., Marin-Husstege M., Kageyama R., Fan Y., Gelinas C., Casaccia-Bonnefil P. A molecular insight of Hes5-dependent inhibition of myelin gene expression: old partners and new players. EMBO J. 2006, 25:4833-4842.
41. Liu A., Han Y.R., Li J., Sun D., Ouyang M., Plummer M.R., Casaccia-Bonnefil P. The glial or neuronal fate choice of oligodendrocyte progenitors is modulated by their ability to acquire an epigenetic memory. J. Neurosci. 2007, 27:7339-7343.
42. Liu Y., Tseng M., Perdreau S.A., Rossi F., Antonescu C., Besmer P., Fletcher J.A., Duensing S., Duensing A. Histone H2AX is a mediator of gastrointestinal stromal tumor cell apoptosis following treatment with imatinib mesylate. Cancer Res. 2007, 67:2685-2692.
43. Liu H., Hu Q., D'ercole A.J., Ye P. Histone deacetylase 11 regulates oligodendrocyte-specific gene expression and cell development in OL-1 oligodendroglia cells. Glia 2009, 57:1-12.
44. Lovis P., Roggli E., Laybutt D.R., Gattesco S., Yang J.Y., Widmann C., Abderrahmani A., Regazzi R. Alterations in microRNA expression contribute to fatty acid-induced pancreatic beta-cell dysfunction. Diabetes 2008, 57:2728-2736.
45. Marin-Husstege M., Muggironi M., Liu A., Casaccia-Bonnefil P. Histone deacetylase activity is necessary for oligodendrocyte lineage progression. J. Neurosci. 2002, 22:10333-10345.
46. Marin-Husstege M., He Y., Li J., Kondo T., Sablitzky F., Casaccia-Bonnefil P. Multiple roles of Id4 in developmental myelination: predicted outcomes and unexpected findings. Glia 2006, 54:285-296.
47. Mastronardi F.G., Wood D.D., Mei J., Raijmakers R., Tseveleki V., Dosch H.M., Probert L., Casaccia-Bonnefil P., Moscarello M.A. Increased citrullination of histone H3 in multiple sclerosis brain and animal models of demyelination: a role for tumor necrosis factor-induced peptidylarginine deiminase 4 translocation. J. Neurosci. 2006, 26:11387-11396.
48. Mastronardi F.G., Noor A., Wood D.D., Paton T., Moscarello M.A. Peptidyl argininedeiminase 2 CpG island in multiple sclerosis white matter is hypomethylated. J. Neurosci. Res. 2007, 85:2006-2016.
49. Mehler M.F. Epigenetics and the nervous system. Ann. Neurol. 2008, 64:602-617.
50. Miller R.H., Mi S. Dissecting demyelination. Nat. Neurosci. 2007, 10:1351-1354.
51. Menn B., Garcia-Verdugo J.M., Yaschine C., Gonzalez-Perez O., Rowitch D., Alvarez-Buylla A. Origin of oligodendrocytes in the subventricular zone of the adult brain. J. Neurosci. 2006, 26:7907-7918.
52. Mori S., Leblond C.P. Electron microscopic identification of three classes of oligodendrocytes and a preliminary study of their proliferative activity in the corpus callosum of young rats. J. Comp. Neurol. 1970, 139:1-28.
53. Moscarello M.A., Wood D.D., Ackerley C., Boulias C. Myelin in multiple sclerosis is developmentally immature. J. Clin. Invest. 1994, 94:146-154.
54. Nicolay D.J., Doucette J.R., Nazarali A.J. Transcriptional control of oligodendrogenesis. Glia 2007, 55:1287-1299.
55. Nielsen J.A., Hudson L.D., Armstrong R.C. Nuclear organization in differentiating oligodendrocytes. J. Cell. Sci. 2002, 115:4071-4079.
56. Ooi S.K., Qiu C., Bernstein E., Li K., Jia D., Yang Z., Erdjument-Bromage H., Tempst P., Lin S.P., Allis C.D., Cheng X., Bestor T.H. DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA. Nature 2007, 448:714-717.
57. Padiath Q.S., Saigoh K., Schiffmann R., Asahara H., Yamada T., Koeppen A., Hogan K., Ptácek L.J., Fu Y.H. Lamin B1 duplications cause autosomal dominant leukodystrophy. Nat. Genet. 2006, 38:1114-1123.
58. Pal S., Vishwanath S.N., Erdjument-Bromage H., Tempst P., Sif S. Human SWI/SNF-associated PRMT5 methylates histone H3 arginine 8 and negatively regulates expression of ST7 and NM23 tumor suppressor genes. Mol. Cell. Biol. 2004, 9630-9645.
59. Papagiannakopoulos T., Shapiro A., Kosik K.S. MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Cancer Res. 2008, 68:8164-8172.
60. Peters A., Palay S.L., Webster H.D.F. The Fine Structure of the Nervous System: Neurons and Their Supporting Cells 2001, Oxford Univ. Press, New York.
61. Robinsin P.J., Rhodes D. Structure of the 30 nm chromatin fiber: a key role for the linker histone. Curr. Opin. Struct. Biol. 2006, 16:336-343.
62. Samanta J., Kessler J.A. Interactions between ID, OLIG proteins mediate the inhibitory effects of BMP4 on oligodendroglial differentiation. Development 2004, 131:4131-4142.
63. Sarma K., Reinberg D. Histone variants meet their match. Nat. Rev. Mol. Cell Biol. 2005, 6:139-149.
64. Sayed D., Hong C., Chen I.Y., Lypowy J., Abdellatif M. MicroRNAs play an essential role in the development of cardiac hypertrophy. Circ. Res. 2007, 100:416-424.
65. Scaffidi P., Misteli T. Lamin A-dependent nuclear defects in human aging. Science 2006, 312:1059-1063.
66. Schneider R., Grosschedl R. Dynamics and interplay of nuclear architecture, genome organization, and gene expression. Genes Dev. 2007, 21:3027-3043.
67. Sekeri-Pataryas K.E., Sourlingas T.G. The differentiation-associated linker histone, H1.0, during the in vitro aging and senescence of human diploid fibroblasts. Ann. N. Y. Acad. Sci. 2007, 1100:361-367.
68. Sempere L.F., Freemantle S., Pitha-Rowe I., Moss E., Dmitrovsky E., Ambros V. Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol. 2004, 5:R13.
69. Shen S., Casaccia-Bonnefil P. Post-translational modifications of nucleosomal histones in oligodendrocyte lineage cells in development and disease. J. Mol. Neurosci. 2008, 35:13-22.
70. Shen S., Li J., Casaccia-Bonnefil P. Histone modifications affect timing of oligodendrocyte progenitor differentiation in the developing rat brain. J. Cell. Biol. 2005, 169:577-589.
71. Shen S., Liu A., Li J., Wolubah C., Casaccia-Bonnefil P. Epigenetic memory loss in aging oligodendrocytes in the corpus callosum. Neurobiol. Aging 2008, 29:452-463.
72. Shen S., Sandoval J., Swiss V.A., Li J., Dupree J., Franklin R.J., Casaccia-Bonnefil P. Age-dependent epigenetic control of differentiation inhibitors is critical for remyelination efficiency. Nat. Neurosci. 2008, 11:1024-1034.
73. Sher F., Rossler R., Brouwer N., Balasubramaniyan V., Boddeke E., Copray S. Differentiation of neural stem cells into oligodendrocytes: involvement of the polycomb group protein Ezh2. Stem Cells 2008, 26:2875-2883.
74. Shi L., Cheng Z., Zhang J., Li R., Zhao P., Fu Z., You Y. hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells. Brain Res. 2008, 1236:185-193.
75. Shields S.A., Gilson J.M., Blakemore W.F., Franklin R.J. Remyelination occurs as extensively but more slowly in old rats compared to young rats following gliotoxin-induced CNS demyelination. Glia 1999, 28:77-83.
76. Shukla A., Chaurasia P., Bhaumik S.R. Histone methylation and ubiquitination with their cross-talk and roles in gene expression and stability. Cell. Mol. Life Sci. 2009, 66:1419-1433.
77. Sim F.J., Zhao C., Penderis J., Franklin R.J. The age-related decrease in CNS remyelination efficiency is attributable to an impairment of both oligodendrocyte progenitor recruitment and differentiation. J. Neurosci. 2002, 22:2451-2459.
78. Sims R.J., Reinberg D. Is there a code embedded in proteins that is based on post-translational modifications?. Nat. Rev. Mol. Cell Biol. 2008, 9:815-820.
79. Srivastava N., Gochhait S., Gupta P., Bamezai R.N. Copy number alterations of the H2AFX gene in sporadic breast cancer patients. Cancer Genet. Cytogenet. 2008, 180:121-128.
80. Stefani G., Slack F.J. Small non-coding RNAs in animal development. Nat. Rev. Mol. Cell Biol. 2008, 9:219-230.
81. Stolt C.C., Rehberg S., Ader M., Lommes P., Riethmacher D., Schachner M., Bartsch U., Wegner M. Terminal differentiation of myelin-forming oligodendrocytes depends on the transcription factor Sox10. Genes Dev. 2002, 16:165-170.
82. Strahl B.D., Briggs S.D., Brame C.J., Caldwell J.A., Koh S.S., Ma H., Cook R.G., Shabanowitz J., Hunt D.F., Stallcup M.R., Allis C.D. Methylation of histone H4 at arginine 3 occurs in vivo and is mediated by the nuclear receptor coactivator PRMT1. Curr. Biol. 2001, 11:996-1000.
83. Sturrock R.R. Light microscopic identification of immature glial cells in semithin sections of the developing mouse corpus callosum. J. Anat. 1976, 122:521-537.
84. Tang X., Tang G., Ozcan S. Role of microRNAs in diabetes. Biochim. Biophys. Acta 2008, 1779:697-701.
85. Thum T., Gross C., Fiedler J., Fischer T., Kissler S., Bussen M., Galuppo P., Just S., Rottbauer W., Frantz S., Castoldi M., Soutschek J., Koteliansky V., Rosenwald A., Basson M.A., Licht J.D., Pena J.T., Rouhanifard S.H., Muckenthaler M.U., Tuschl T., Martin G.R., Bauersachs J., Engelhardt S. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 2008, 456:980-984.
86. Ushijima T. Detection and interpretation of altered methylation patterns in cancer cells. Nat. Rev. Cancer 2005, 5:223-231.
87. Ye F., Chen Y., Hoang T., Montgomery R.L., Zhao X.H., Bu H., Hu T., Taketo M.M., van Es J.H., Clevers H., Hsieh J., Bassel-Duby R., Olson E.N., Lu Q.R. HDAC1 and HDAC2 regulate oligodendrocyte differentiation by disrupting the beta-catenin-TCF interaction. Nat. Neurosci. 2009, 12:829-838.
88. Wang H., Huang Z.Q., Xia L., Feng Q., Erdjument-Bromage H., Strahl B.D., Briggs S.D., Allis C.D., Wong J., Tempst P., Zhang Y. Methylation of histone H4 arginine 3 facilitating transcriptional activation by nuclear hormone receptor. Science 2001, 293:853-857.
89. Wang Y., Wysocka J., Sayegh J., Lee Y.H., Perlin J.R., Leonelli L., Sonbuchner L.S., McDonald C.H., Cook R.G., Dou Y., Roeder R.G., Clarke S., Stallcup M.R., Allis C.D., Coonrod S.A. Human PAD4 regulates histone arginine methylation levels via demethylimination. Science 2004, 306:279-283.
90. Wegner M. A matter of identity: transcriptional control in oligodendrocytes. J. Mol. Neurosci. 2008, 35:3-12.
91. Williams R.R., Azuara V., Perry P., Sauer S., Dvorkina M., Jørgensen H., Roix J., McQueen P., Misteli T., Merkenschlager M., Fisher A.G. Neural induction promotes large-scale chromatin reorganisation of the Mash1 locus. J. Cell. Sci. 2006, 119:132-140.
92. Wood D.D., Bilbao J.M., O'Connors P., Moscarello M.A. Acute multiple sclerosis (Marburg type) is associated with developmentally immature myelin basic protein. Ann. Neurol. 1996, 40:18-24.
93. Wood D.D., Ackerley C.A., Brand B., Zhang L., Raijmakers R., Mastronardi F.G., Moscarello M.A. Myelin localization of peptidylarginine deiminases 2 and 4: comparison of PAD2 and PAD4 activities. Lab. Invest. 2008, 88:354-364.
94. Woodcock C.L., Skoultchi A.I., Fan Y. Role of linker histone in chromatin structure and function: H1 stoichiometry and nucleosome repeat length. Chromosome Res. 2006, 14:17-25.
95. Wysocka J., Allis C.D., Coonrod S. Histone arginine methylation and its dynamic regulation. Front. Biosci. 2006, 11:344-355.